AI 진단 영상 시장 예측(-2034년) : 구성 요소, 영상 진단법, 기술, 도입 형태, 임상 응용, AI 솔루션, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global AI Diagnostic Imaging Market is accounted for $2.2 billion in 2026 and is expected to reach $10.8 billion by 2034 growing at a CAGR of 21.8% during the forecast period. The AI Diagnostic Imaging market encompasses artificial intelligence solutions designed to enhance the interpretation and analysis of medical images across various healthcare disciplines. Advanced machine learning and deep learning models help clinicians identify diseases, automate image assessments, prioritize urgent examinations, and provide decision support using modalities such as MRI, CT, X-ray, ultrasound, and mammography. Rising demand for faster diagnostics, expanding medical imaging procedures, and continued progress in AI technologies are accelerating market growth. These solutions improve operational efficiency, increase diagnostic precision, reduce clinician workload, enable earlier diagnosis, and strengthen patient care in hospitals, imaging centers, and specialized healthcare facilities.

Market Dynamics:

Driver:

Increasing Volume of Medical Imaging Procedures

A substantial increase in medical imaging examinations is accelerating the adoption of artificial intelligence within diagnostic imaging. Hospitals and diagnostic centers are handling larger numbers of imaging studies due to the growing prevalence of chronic illnesses, an aging global population, and broader healthcare accessibility. AI systems streamline image interpretation by automating repetitive tasks, organizing case priorities, and assisting radiologists in delivering timely reports. These capabilities enhance productivity while maintaining consistent diagnostic quality. As healthcare providers seek effective ways to address increasing imaging demand without compromising patient care, AI-enabled diagnostic imaging platforms are becoming valuable tools for improving operational performance.

Restraint:

High Implementation and Infrastructure Costs

The considerable cost associated with implementing artificial intelligence in diagnostic imaging presents a major challenge for market growth. Healthcare providers must invest in powerful computing systems, secure digital infrastructure, AI software platforms, integration with existing hospital systems, and continuous technical support. Additional expenses for staff education, cybersecurity upgrades, and software maintenance further increase ownership costs. Smaller healthcare facilities and organizations operating with restricted budgets often postpone AI adoption because of financial limitations. These economic barriers are particularly evident in emerging healthcare markets, where funding priorities focus on essential medical services before advanced digital technologies, limiting broader deployment of AI imaging solutions.

Opportunity:

Rising Demand for AI-Enabled Remote Diagnostics and Tele-Radiology

Growing adoption of remote healthcare services is creating valuable opportunities for artificial intelligence in diagnostic imaging. AI-powered imaging platforms allow radiologists to interpret medical scans from different locations while automatically identifying high-priority cases and improving reporting efficiency. These capabilities expand access to specialized diagnostic expertise in regions with limited medical resources. Continued investments in telehealth technologies, digital connectivity, and remote clinical services are increasing demand for intelligent imaging solutions. As healthcare organizations strengthen virtual care delivery, AI-supported tele-radiology platforms are expected to become increasingly important for providing accurate, timely, and accessible diagnostic imaging across geographically distributed healthcare networks.

Threat:

Intense Market Competition and Pricing Pressure

Strong competition within the AI Diagnostic Imaging industry creates ongoing challenges for technology providers. Global healthcare companies and innovative startups are rapidly introducing advanced imaging solutions, increasing pressure to deliver superior performance at competitive prices. Healthcare organizations often evaluate vendors based on clinical accuracy, interoperability, ease of implementation, and overall value, forcing companies to invest continuously in product improvement. Businesses with limited resources may find it difficult to match the research capabilities, marketing strength, and international presence of larger competitors. These competitive pressures can reduce profit margins and make sustained market growth more difficult.

Covid-19 Impact:

The COVID-19 outbreak accelerated the growth of the AI Diagnostic Imaging market by highlighting the importance of fast, accurate, and automated medical image interpretation. Healthcare providers adopted AI solutions to analyze chest CT scans and X-rays for detecting respiratory complications associated with COVID-19, enabling quicker diagnosis and improved patient prioritization. Increased pressure on radiology departments encouraged greater use of workflow automation and intelligent decision-support systems. While routine diagnostic imaging volumes declined temporarily because of postponed elective procedures, investments in digital health, cloud-based imaging, and remote radiology expanded significantly, creating lasting opportunities for AI-driven diagnostic imaging across global healthcare systems.

The Software segment is expected to be the largest during the forecast period

The Software segment is expected to account for the largest market share during the forecast period, supported by its powers intelligent image interpretation, automated reporting, and clinical decision support throughout healthcare organizations. AI-based software can be deployed across existing imaging infrastructure, allowing providers to strengthen diagnostic workflows while maximizing the value of current medical equipment. Ongoing improvements in artificial intelligence models, interoperability, and cloud-enabled platforms continue to expand software capabilities and clinical applications. Its flexibility, ease of integration, continuous upgrades, and widespread implementation across hospitals, imaging centers, and healthcare networks establish software as the leading component within the AI diagnostic imaging ecosystem.

The Digital Pathology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Digital Pathology segment is predicted to witness the highest growth rate in the AI Diagnostic Imaging market as healthcare providers increasingly adopt integrated imaging approaches supported by artificial intelligence. By combining data from multiple imaging techniques, AI enables more comprehensive disease evaluation, greater diagnostic precision, and improved treatment planning. Expanding use in cancer diagnosis, neurological disorders, and cardiovascular diseases is driving demand for advanced image fusion and analytics technologies. Continuous innovation in AI algorithms, growing interoperability between imaging systems, and rising emphasis on precision medicine are expected to accelerate adoption, positioning multimodal imaging as the fastest-growing application segment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, because of its mature healthcare ecosystem, extensive use of advanced medical technologies, and concentration of major AI and imaging solution providers. Healthcare organizations throughout the region actively deploy artificial intelligence to optimize radiology operations, accelerate image analysis, and support clinical decision-making. Strong investments in healthcare digitization, research initiatives, and technological innovation continue to expand AI applications across diagnostic imaging. Supportive regulatory advancements, substantial healthcare spending, and increasing emphasis on early disease detection and precision medicine reinforce North America's dominant position in the global AI diagnostic imaging market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, because of its advanced medical infrastructure, early adoption of digital healthcare technologies, and strong concentration of leading AI and imaging solution providers. Hospitals, imaging centers, and healthcare networks increasingly integrate artificial intelligence into routine diagnostic workflows to improve efficiency, reduce reporting time, and support clinical decision-making. Continuous investments in innovation, widespread implementation of electronic health systems, and robust research activities accelerate market growth. Strong regulatory support, expanding use of intelligent imaging platforms, and increasing focus on personalized healthcare further solidify North America's leadership in the global AI Diagnostic Imaging market.

Key players in the market

Some of the key players in AI Diagnostic Imaging Market include GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Bayer AG, Aidoc Medical Ltd., Viz.ai, Inc., Gleamer SAS, Lunit Inc., Qure.ai Technologies Pvt. Ltd., Nanox Imaging Ltd., Subtle Medical, Inc., RadNet, Inc., iCAD, Inc., Riverain Technologies LLC, ScreenPoint Medical B.V. and Annalise.ai Pty Ltd.

Key Developments:

In May 2026, Fujifilm partnered with Ardent Health to deploy the Synapse Enterprise Imaging platform across Ardent Health's radiology and cardiology departments, strengthening enterprise imaging workflows with AI-enabled imaging informatics and clinical collaboration.

In March 2026, GE HealthCare and Stanford Radiology expanded their long-term research collaboration by establishing a Center of Excellence focused on advancing next-generation imaging.

In February 2026, Siemens Healthineers and Mayo Clinic expanded their strategic collaboration to advance patient care through AI-enabled imaging technologies, digital innovation, and research focused on improving diagnostic and clinical outcomes.

Components Covered:

• Software
• Hardware
• Services

Imaging Modalities Covered:

• X-ray
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Ultrasound
• Mammography
• Positron Emission Tomography (PET)
• Single Photon Emission Computed Tomography (SPECT)
• Digital Pathology
• Multimodal Imaging

Technologies Covered:

• Machine Learning
• Deep Learning
• Computer Vision
• Natural Language Processing
• Generative AI

Deployment Modes Covered:

• On-Premises
• Cloud-Based
• Hybrid

Clinical Applications Covered:

• Oncology
• Neurology
• Cardiology
• Pulmonology
• Orthopedics
• Gastroenterology
• Urology
• Obstetrics & Gynecology
• Emergency & Trauma Care
• Other Clinical Applications

AI Solutions Covered:

• Image Acquisition Optimization
• Image Reconstruction & Enhancement
• Computer-Aided Detection (CADe)
• Computer-Aided Diagnosis (CADx)
• Image Quantification
• Clinical Decision Support
• Reporting & Documentation
• Workflow Prioritization & Triage

End Users Covered:

• Hospitals
• Diagnostic Imaging Centers
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)
• Academic & Research Institutes

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
    • Saudi Arabia
    • United Arab Emirates
    • Qatar
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Egypt
    • Morocco
    • Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global AI Diagnostic Imaging Market, By Component

• 5.1 Software
• 5.2 Hardware
• 5.3 Services

6 Global AI Diagnostic Imaging Market, By Imaging Modality

• 6.1 X-ray
• 6.2 Computed Tomography (CT)
• 6.3 Magnetic Resonance Imaging (MRI)
• 6.4 Ultrasound
• 6.5 Mammography
• 6.6 Positron Emission Tomography (PET)
• 6.7 Single Photon Emission Computed Tomography (SPECT)
• 6.8 Digital Pathology
• 6.9 Multimodal Imaging

7 Global AI Diagnostic Imaging Market, By Technology

• 7.1 Machine Learning
• 7.2 Deep Learning
• 7.3 Computer Vision
• 7.4 Natural Language Processing
• 7.5 Generative AI

8 Global AI Diagnostic Imaging Market, By Deployment Mode

• 8.1 On-Premises
• 8.2 Cloud-Based
• 8.3 Hybrid

9 Global AI Diagnostic Imaging Market, By Clinical Application

• 9.1 Oncology
• 9.2 Neurology
• 9.3 Cardiology
• 9.4 Pulmonology
• 9.5 Orthopedics
• 9.6 Gastroenterology
• 9.7 Urology
• 9.8 Obstetrics & Gynecology
• 9.9 Emergency & Trauma Care
• 9.10 Other Clinical Applications

10 Global AI Diagnostic Imaging Market, By AI Solution

• 10.1 Image Acquisition Optimization
• 10.2 Image Reconstruction & Enhancement
• 10.3 Computer-Aided Detection (CADe)
• 10.4 Computer-Aided Diagnosis (CADx)
• 10.5 Image Quantification
• 10.6 Clinical Decision Support
• 10.7 Reporting & Documentation
• 10.8 Workflow Prioritization & Triage

11 Global AI Diagnostic Imaging Market, By End User

• 11.1 Hospitals
• 11.2 Diagnostic Imaging Centers
• 11.3 Specialty Clinics
• 11.4 Ambulatory Surgical Centers (ASCs)
• 11.5 Academic & Research Institutes

12 Global AI Diagnostic Imaging Market, By Geography

• 12.1 North America
  • 12.1.1 United States
  • 12.1.2 Canada
  • 12.1.3 Mexico
• 12.2 Europe
  • 12.2.1 United Kingdom
  • 12.2.2 Germany
  • 12.2.3 France
  • 12.2.4 Italy
  • 12.2.5 Spain
  • 12.2.6 Netherlands
  • 12.2.7 Belgium
  • 12.2.8 Sweden
  • 12.2.9 Switzerland
  • 12.2.10 Poland
  • 12.2.11 Rest of Europe
• 12.3 Asia Pacific
  • 12.3.1 China
  • 12.3.2 Japan
  • 12.3.3 India
  • 12.3.4 South Korea
  • 12.3.5 Australia
  • 12.3.6 Indonesia
  • 12.3.7 Thailand
  • 12.3.8 Malaysia
  • 12.3.9 Singapore
  • 12.3.10 Vietnam
  • 12.3.11 Rest of Asia Pacific
• 12.4 South America
  • 12.4.1 Brazil
  • 12.4.2 Argentina
  • 12.4.3 Colombia
  • 12.4.4 Chile
  • 12.4.5 Peru
  • 12.4.6 Rest of South America
• 12.5 Rest of the World (RoW)
  • 12.5.1 Middle East
    • 12.5.1.1 Saudi Arabia
    • 12.5.1.2 United Arab Emirates
    • 12.5.1.3 Qatar
    • 12.5.1.4 Israel
    • 12.5.1.5 Rest of Middle East
  • 12.5.2 Africa
    • 12.5.2.1 South Africa
    • 12.5.2.2 Egypt
    • 12.5.2.3 Morocco
    • 12.5.2.4 Rest of Africa

13 Strategic Market Intelligence

• 13.1 Industry Value Network and Supply Chain Assessment
• 13.2 White-Space and Opportunity Mapping
• 13.3 Product Evolution and Market Life Cycle Analysis
• 13.4 Channel, Distributor, and Go-to-Market Assessment

14 Industry Developments and Strategic Initiatives

• 14.1 Mergers and Acquisitions
• 14.2 Partnerships, Alliances, and Joint Ventures
• 14.3 New Product Launches and Certifications
• 14.4 Capacity Expansion and Investments
• 14.5 Other Strategic Initiatives

15 Company Profiles

• 15.1 GE HealthCare Technologies Inc.
• 15.2 Siemens Healthineers AG
• 15.3 Koninklijke Philips N.V.
• 15.4 Canon Medical Systems Corporation
• 15.5 Fujifilm Holdings Corporation
• 15.6 Bayer AG
• 15.7 Aidoc Medical Ltd.
• 15.8 Viz.ai, Inc.
• 15.9 Gleamer SAS
• 15.10 Lunit Inc.
• 15.11 Qure.ai Technologies Pvt. Ltd.
• 15.12 Nanox Imaging Ltd.
• 15.13 Subtle Medical, Inc.
• 15.14 RadNet, Inc.
• 15.15 iCAD, Inc.
• 15.16 Riverain Technologies LLC
• 15.17 ScreenPoint Medical B.V.
• 15.18 Annalise.ai Pty Ltd.